MarketWatch - Top Stories

MarketWatch, a leading publisher of business and financial news, offers users up-to-the minute news, investment tools, and subscription products.
  1. The company could be delaying price information because it’ll be higher than expected, according to some.
  2. The nonprofit ICER said last week the drug would likely be more expensive but is an important product nonetheless.
  3. MaxLinear is paying $13 for each Exar share, or about $661.6 million in cash.
  4. Oil prices continue to climb on Wednesday, boosted by supply disruptions in Libya and hopes official U.S. inventory data will show a drawdown in supplies at a major storage hub.
  5. Everyone wants tax reform until it comes to sacrificing his or her loophole, writes Caroline Baum, explaining why tax reform isn’t as simple as it may appear.
  6. U.S. stock futures point to a muted open Wednesday, with the Dow poised to catch its breath after a 151 point gain that followed better-than-expected economic reports.
  7. Westinghouse incurred billions of dollars of cost overruns building the nuclear reactors in Georgia and South Carolina, a financial disaster that threatens parent company Toshiba’s viability.
  8. Prime Minister Theresa May‘s notification is on its way to the EU, opening a two-year window for negotiations to extricate Britain from the bloc.
  9. More than half of the visitors came from just one of the six countries.
  10. State governments earn nearly a trillion dollars each year through taxes, but not all that money is well spent.